CA - Knight Therapeutics Inc. (KHTRF) Q1 2024 Earnings Call Transcript
2024-05-11 03:53:01 ET
Knight Therapeutics, Inc. (KHTRF)
Q1 2024 Earnings Conference Call
May 9, 2024, 8:30 am ET
Company Participants
Samira Sakhia - President & CEO
Amal Khouri - CBO
Arvind Utchanah - CFO
Conference Call Participants
Andre Uddin - Research Capital
Rahul Sarugaser - Raymond James
Scott McAuley - Paradigm Capital
Doug Miehm - RBC Capital Markets
Presentation
Operator
Good morning, ladies and gentlemen. My name is Liz and I will be your operator today. Welcome to Knight Therapeutics First Quarter 2024 Results Conference Call.
Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today's discussion may by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements.
The company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the company and its subsidiaries may ultimately prove to be incorrect.
The company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events, except as required by law. We would also like to remind you questions during today's call will be taken from analysts only. Should there be any further questions, please contact Knight's Investor Relations department via email to info@knighttx.com or via phone at (514) 484-4483. I would like to remind everyone that this call is being recorded today, May 9, 2024....
Knight Therapeutics, Inc. (KHTRF) Q1 2024 Earnings Call Transcript